Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Glioblastoma

  • You have access
    HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation
    TOMAS HRBAC, ALENA KOPKOVA, FRANTISEK SIEGL, MAREK VECERA, MICHAELA RUCKOVA, TOMAS KAZDA, RADIM JANCALEK, MICHAL HENDRYCH, MARKETA HERMANOVA, VACLAV VYBIHAL, PAVEL FADRUS, MARTIN SMRCKA, FILIP SOKOL, VACLAV KUBES, RADIM LIPINA, ONDREJ SLABY, LEOS KREN and JIRI SANA
    Cancer Genomics & Proteomics March 2022, 19 (2) 151-162; DOI: https://doi.org/10.21873/cgp.20311
  • Open Access
    Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas
    NARA YOON, HYUN-SOO KIM, JUNG WHEE LEE, EUI-JIN LEE, LEE-SO MAENG and WAN SOO YOON
    Cancer Genomics & Proteomics November 2020, 17 (6) 803-812; DOI: https://doi.org/10.21873/cgp.20234
  • Open Access
    MGMT Gene Promoter Methylation Status – Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas
    LENE E. JOHANNESSEN, PETTER BRANDAL, TOR ÅGE MYKLEBUST, SVERRE HEIM, FRANCESCA MICCI and IOANNIS PANAGOPOULOS
    Cancer Genomics & Proteomics November 2018, 15 (6) 437-446; DOI: https://doi.org/10.21873/cgp.20102
  • Open Access
    Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the SGK1 Gene Are Associated with Poorer Survival
    STEVEN LEHRER, PETER H. RHEINSTEIN and KENNETH E. ROSENZWEIG
    Cancer Genomics & Proteomics July 2018, 15 (4) 273-278; DOI: https://doi.org/10.21873/cgp.20085
  • Open Access
    Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line
    HARUO MIYATA, TADASHI ASHIZAWA, AKIRA IIZUKA, RYOTA KONDOU, CHIZU NONOMURA, TAKASHI SUGINO, KENICHI URAKAMI, AKIRA ASAI, NAKAMASA HAYASHI, KOICHI MITSUYA, YOKO NAKASU, KEN YAMAGUCHI and YASUTO AKIYAMA
    Cancer Genomics & Proteomics January 2017, 14 (1) 83-91;
Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire